# Sangamo Therapeutics, Inc: Form 8-K, filed Feb 6, 2025

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: 8-K
- Filed: 2025-02-06
- Accepted by EDGAR: Feb 6, 2025, 08:13 ET
- Period: 2025-02-06
- Accession: 0001628280-25-004197
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000162828025004197/sgmo-20250206.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000162828025004197/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000162828025004197/sgmo-20250206.htm

Filed Feb 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-004197. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.